Zuleima Lozada, APRN

Zuleima Lozada practices at Collier Surgery Center,LLP in Naples, Florida.

Zuleima Lozada's NPI, 1194350348, was assigned on March 9, 2020. Zuleima Lozada holds Florida license APRN11006266.

Zuleima Lozada's primary practice is Collier Surgery Center,LLP, at 800 Goodlette N Rd, Naples, FL 34102 in Collier County. The practice phone is (239) 262-5757.

Zuleima Lozada's primary practice is Collier Surgery Center,LLP in Naples, Florida. Zuleima Lozada is also affiliated with NCH Baker Hospital. The medical group on file is Millennium Physician Group. Dmand AI also links Zuleima Lozada to 1 more hospital, 2 group practices and clinics, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Zuleima Lozada practices, 6 sites in all. Vendor and product names are available with a free account.

Family is Zuleima Lozada's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Zuleima Lozada is licensed in Florida.

Dmand AI lists acute gastroduodenitis, acute sinusitis, acute skin infection, arthritis, asthma, bronchitis, chronic diabetes and chronic kidney disease among the conditions Zuleima Lozada treats.

CMS data shows 1,696 Medicare services from Zuleima Lozada across 17 procedure codes in 2024, for 298 Medicare patients. Medicare paid $87,477 for them. Every service was in an office.

CMS counts 298 Medicare patients who saw Zuleima Lozada in 2024. The largest group is 75 to 84, with 145 patients. 75% of them have high cholesterol, and 69% have high blood pressure. Their average risk score is 1.08, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Zuleima Lozada's median patient age at 70, with 74% women.

In 2024, Zuleima Lozada wrote 2,839 Medicare Part D claims for 371 patients. 88% of them were for generic drugs. CMS names the drug for 2,314 of them, across 61 drugs with 11 or more claims each, at $177,581 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Zuleima Lozada for performance year 2024, reported through an alternative payment model (APM). Zuleima Lozada accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Zuleima Lozada as offering telehealth.

CMS Open Payments shows 6 general payments to Zuleima Lozada from 5 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Madrigal Pharmaceuticals paid the most, $141.